PMV Capital Advisers »

Regeneron Pharmaceuticals shares owned by PMV Capital Advisers

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by PMV Capital Advisers from 13F filings

Historical chart of PMV Capital Advisers investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by PMV Capital Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by PMV Capital Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $19k 24 772.54

More positions owned by PMV Capital Advisers

Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
Ishares Tr Core S&p500 Etf (IVV)
Simplify Exchange Traded Fun Managed Futures (CTA)
Proshares Tr Ii Ultra Gold (UGL)
Agf Invts Tr Us Market Netrl (BTAL)
Spdr Gold Tr Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Proshares Tr Pshs Ult S&p 500 (SSO)
Proshares Tr Pshs Ultra Qqq (QLD)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Proshares Tr Ultrapro Qqq (TQQQ)
Apple (AAPL)
Direxion Shs Etf Tr Drx S&p500bull (SPXL)
Proshares Tr Ultra 20yr Tre (UBT)
Proshares Tr Ultr Msci Etf (EFO)

View all positions for PMV Capital Advisers

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals